# Nurix Therapeutics, Inc.: Form 8-K, filed Oct 12, 2023

- Company: [Nurix Therapeutics, Inc.](/companies/nrix.md) (CIK 1549595)
- Form: 8-K
- Filed: 2023-10-12
- Accepted by EDGAR: Oct 12, 2023, 16:03 ET
- Period: 2023-10-12
- Accession: 0001549595-23-000046
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1549595/000154959523000046/nrix-20231012.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1549595/000154959523000046/

## Items reported

- Item 2.02: Results of operations

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1549595/000154959523000046/nrix-20231012.htm

Filed Oct 12, 2023.
Source: SEC EDGAR, the filing index for accession 0001549595-23-000046. Last ingested by Listed: Nov 5, 2026, 13:59 ET. No prices; not investment advice.